# Nextpower Inc.: financial statements, quarterly

NXT · Nasdaq · CIK 1852131 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/nxt.md) · [Financials](/companies/nxt/financials.md) · [Filings](/companies/nxt/filings.md) · [Insiders](/companies/nxt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nxt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-29) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-28) | Q2 FY2025 (2024-09-27) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-27) | Q2 FY2026 (2025-09-26) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [573](/filings/0001852131-24-000025.md) | [710](/filings/0001852131-25-000006.md) | [737 d](/filings/0001852131-26-000017.md) | [720](/filings/0001852131-25-000050.md) | [636](/filings/0001852131-25-000064.md) | [679](/filings/0001852131-26-000006.md) | [924 d](/filings/0001852131-26-000017.md) | [864](/filings/0001852131-26-000048.md) | [905](/filings/0001852131-25-000064.md) | [909](/filings/0001852131-26-000006.md) | [881 d](/filings/0001852131-26-000017.md) | [935](/filings/0001852131-26-000048.md) |
| Cost of revenue | $m | [424](/filings/0001852131-24-000025.md) | [501](/filings/0001852131-25-000006.md) | [396 d](/filings/0001852131-26-000017.md) | [482](/filings/0001852131-25-000050.md) | [411](/filings/0001852131-25-000064.md) | [438](/filings/0001852131-26-000006.md) | [619 d](/filings/0001852131-26-000017.md) | [583](/filings/0001852131-26-000048.md) | [612](/filings/0001852131-25-000064.md) | [621](/filings/0001852131-26-000006.md) | [583 d](/filings/0001852131-26-000017.md) | [599](/filings/0001852131-26-000048.md) |
| Gross profit | $m | [149](/filings/0001852131-24-000025.md) | [210](/filings/0001852131-25-000006.md) | [340 d](/filings/0001852131-26-000017.md) | [237](/filings/0001852131-25-000050.md) | [225](/filings/0001852131-25-000064.md) | [241](/filings/0001852131-26-000006.md) | [306 d](/filings/0001852131-26-000017.md) | [282](/filings/0001852131-26-000048.md) | [293](/filings/0001852131-25-000064.md) | [288](/filings/0001852131-26-000006.md) | [297 d](/filings/0001852131-26-000017.md) | [336](/filings/0001852131-26-000048.md) |
| Research and development | $m | [7.1](/filings/0001852131-24-000025.md) | [12.9](/filings/0001852131-25-000006.md) | [13.1 d](/filings/0001852131-26-000017.md) | [16.5](/filings/0001852131-25-000050.md) | [19.2](/filings/0001852131-25-000064.md) | [20.1](/filings/0001852131-26-000006.md) | [23.6 d](/filings/0001852131-26-000017.md) | [21.6](/filings/0001852131-26-000048.md) | [26.9](/filings/0001852131-25-000064.md) | [29.3](/filings/0001852131-26-000006.md) | [43.2 d](/filings/0001852131-26-000017.md) | [44.5](/filings/0001852131-26-000048.md) |
| Selling, general and administrative | $m | [47.9](/filings/0001852131-24-000025.md) | [48.4](/filings/0001852131-25-000006.md) | [56.7 d](/filings/0001852131-26-000017.md) | [60.8](/filings/0001852131-25-000050.md) | [72.1](/filings/0001852131-25-000064.md) | [70.6](/filings/0001852131-26-000006.md) | [86.8 d](/filings/0001852131-26-000017.md) | [73.9](/filings/0001852131-26-000048.md) | [84.6](/filings/0001852131-25-000064.md) | [82.7](/filings/0001852131-26-000006.md) | [101 d](/filings/0001852131-26-000017.md) | [100](/filings/0001852131-26-000048.md) |
| Operating income | $m | [94.1](/filings/0001852131-24-000025.md) | [148](/filings/0001852131-25-000006.md) | [271 d](/filings/0001852131-26-000017.md) | [160](/filings/0001852131-25-000050.md) | [133](/filings/0001852131-25-000064.md) | [150](/filings/0001852131-26-000006.md) | [195 d](/filings/0001852131-26-000017.md) | [186](/filings/0001852131-26-000048.md) | [181](/filings/0001852131-25-000064.md) | [176](/filings/0001852131-26-000006.md) | [154 d](/filings/0001852131-26-000017.md) | [191](/filings/0001852131-26-000048.md) |
| Income tax | $m | [4.0](/filings/0001852131-24-000025.md) | [38.8](/filings/0001852131-25-000006.md) | [59.9 d](/filings/0001852131-26-000017.md) | [27.2](/filings/0001852131-25-000050.md) | [19.9](/filings/0001852131-25-000064.md) | [42.8](/filings/0001852131-26-000006.md) | [40.8 d](/filings/0001852131-26-000017.md) | [33.8](/filings/0001852131-26-000048.md) | [35.9](/filings/0001852131-25-000064.md) | [49.3](/filings/0001852131-26-000006.md) | [9.0 d](/filings/0001852131-26-000017.md) | [33.6](/filings/0001852131-26-000048.md) |
| Net income | $m | [39.3](/filings/0001852131-24-000025.md) | [41.4](/filings/0001852131-25-000006.md) | [205 d](/filings/0001852131-26-000017.md) | [122](/filings/0001852131-25-000050.md) | [115](/filings/0001852131-25-000064.md) | [115](/filings/0001852131-26-000006.md) | [157 d](/filings/0001852131-26-000017.md) | [157](/filings/0001852131-26-000048.md) | [147](/filings/0001852131-25-000064.md) | [131](/filings/0001852131-26-000006.md) | [151 d](/filings/0001852131-26-000017.md) | [165](/filings/0001852131-26-000048.md) |
| Diluted EPS | $ per share | [0.55](/filings/0001852131-24-000025.md) | [0.87](/filings/0001852131-25-000006.md) | not reported | [0.84](/filings/0001852131-25-000050.md) | [0.79](/filings/0001852131-25-000064.md) | [0.79](/filings/0001852131-26-000006.md) | not reported | [1.04](/filings/0001852131-26-000048.md) | [0.97](/filings/0001852131-25-000064.md) | [0.85](/filings/0001852131-26-000006.md) | not reported | [1.07](/filings/0001852131-26-000048.md) |
| Basic EPS | $ per share | [0.64](/filings/0001852131-24-000025.md) | [0.67](/filings/0001852131-25-000006.md) | not reported | [0.86](/filings/0001852131-25-000050.md) | [0.80](/filings/0001852131-25-000064.md) | [0.80](/filings/0001852131-26-000006.md) | not reported | [1.06](/filings/0001852131-26-000048.md) | [0.99](/filings/0001852131-25-000064.md) | [0.88](/filings/0001852131-26-000006.md) | not reported | [1.10](/filings/0001852131-26-000048.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-29) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-28) | Q2 FY2025 (2024-09-27) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-27) | Q2 FY2026 (2025-09-26) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [373](/filings/0001852131-23-000007.md) | [368](/filings/0001628280-24-003593.md) | [474](/filings/0001852131-25-000021.md) | [472](/filings/0001852131-24-000015.md) | [562](/filings/0001852131-24-000025.md) | [694](/filings/0001852131-25-000006.md) | [766](/filings/0001852131-26-000017.md) | [743](/filings/0001852131-25-000050.md) | [845](/filings/0001852131-25-000064.md) | [953](/filings/0001852131-26-000006.md) | [1,095](/filings/0001852131-26-000048.md) | [1,214](/filings/0001852131-26-000048.md) |
| Current assets | $m | [1,339](/filings/0001852131-23-000007.md) | [1,419](/filings/0001628280-24-003593.md) | [1,768](/filings/0001852131-25-000021.md) | [1,697](/filings/0001852131-24-000015.md) | [1,785](/filings/0001852131-24-000025.md) | [1,995](/filings/0001852131-25-000006.md) | [2,158](/filings/0001852131-26-000017.md) | [2,233](/filings/0001852131-25-000050.md) | [2,439](/filings/0001852131-25-000064.md) | [2,560](/filings/0001852131-26-000006.md) | [2,847](/filings/0001852131-26-000048.md) | [3,028](/filings/0001852131-26-000048.md) |
| Total assets | $m | [2,034](/filings/0001852131-23-000007.md) | [2,095](/filings/0001628280-24-003593.md) | [2,519](/filings/0001852131-25-000021.md) | [2,627](/filings/0001852131-24-000015.md) | [2,769](/filings/0001852131-24-000025.md) | [2,984](/filings/0001852131-25-000006.md) | [3,193](/filings/0001852131-26-000017.md) | [3,390](/filings/0001852131-25-000050.md) | [3,669](/filings/0001852131-25-000064.md) | [3,800](/filings/0001852131-26-000006.md) | [4,073](/filings/0001852131-26-000048.md) | [4,262](/filings/0001852131-26-000048.md) |
| Current liabilities | $m | [772](/filings/0001852131-23-000007.md) | [759](/filings/0001628280-24-003593.md) | [891](/filings/0001852131-25-000021.md) | [803](/filings/0001852131-24-000015.md) | [806](/filings/0001852131-24-000025.md) | [905](/filings/0001852131-25-000006.md) | [1,034](/filings/0001852131-26-000017.md) | [1,032](/filings/0001852131-25-000050.md) | [1,120](/filings/0001852131-25-000064.md) | [1,085](/filings/0001852131-26-000006.md) | [1,164](/filings/0001852131-26-000048.md) | [1,126](/filings/0001852131-26-000048.md) |
| Total liabilities | $m | [1,358](/filings/0001852131-23-000007.md) | [1,344](/filings/0001628280-24-003593.md) | [1,527](/filings/0001852131-25-000021.md) | [1,490](/filings/0001852131-24-000015.md) | [1,486](/filings/0001852131-24-000025.md) | [1,559](/filings/0001852131-25-000006.md) | [1,564](/filings/0001852131-26-000017.md) | [1,583](/filings/0001852131-25-000050.md) | [1,683](/filings/0001852131-25-000064.md) | [1,649](/filings/0001852131-26-000006.md) | [1,739](/filings/0001852131-26-000048.md) | [1,705](/filings/0001852131-26-000048.md) |
| Long-term debt | $m | [146](/filings/0001852131-23-000007.md) | [145](/filings/0001628280-24-003593.md) | [144](/filings/0001852131-25-000021.md) | [142](/filings/0001852131-24-000015.md) | [141](/filings/0001852131-24-000025.md) | [139](/filings/0001852131-25-000006.md) | [0.0](/filings/0001852131-25-000021.md) | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | [3.8](/filings/0001852131-25-000021.md) | [4.7](/filings/0001852131-24-000015.md) | [5.6](/filings/0001852131-24-000025.md) | [6.6](/filings/0001852131-25-000006.md) | [0.0](/filings/0001852131-25-000021.md) | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(2,641)](/filings/0001628280-24-003593.md) | [(3,117)](/filings/0001628280-24-003593.md) | [992](/filings/0001852131-26-000017.md) | [1,121](/filings/0001852131-24-000015.md) | [1,282](/filings/0001852131-26-000006.md) | [1,425](/filings/0001852131-26-000006.md) | [1,628](/filings/0001852131-26-000048.md) | [1,807](/filings/0001852131-26-000048.md) | [1,986](/filings/0001852131-26-000006.md) | [2,151](/filings/0001852131-26-000006.md) | [2,334](/filings/0001852131-26-000048.md) | [2,557](/filings/0001852131-26-000048.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-29) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-28) | Q2 FY2025 (2024-09-27) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-27) | Q2 FY2026 (2025-09-26) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [26.9 d](/filings/0001852131-24-000025.md) | [64.8 d](/filings/0001852131-25-000006.md) | [111 d](/filings/0001852131-26-000017.md) | [121](/filings/0001852131-25-000050.md) | [154 d](/filings/0001852131-25-000064.md) | [144 d](/filings/0001852131-26-000006.md) | [237 d](/filings/0001852131-26-000017.md) | [81.3](/filings/0001852131-26-000048.md) | [187 d](/filings/0001852131-25-000064.md) | [123 d](/filings/0001852131-26-000006.md) | [171 d](/filings/0001852131-26-000017.md) | [121](/filings/0001852131-26-000048.md) |
| Capital expenditure | $m | [0.7 d](/filings/0001852131-24-000025.md) | [2.4 d](/filings/0001852131-25-000006.md) | [2.3 d](/filings/0001852131-26-000017.md) | [2.9](/filings/0001852131-25-000050.md) | [12.0 d](/filings/0001852131-25-000064.md) | [8.9 d](/filings/0001852131-26-000006.md) | [10.1 d](/filings/0001852131-26-000017.md) | [11.3](/filings/0001852131-26-000048.md) | [15.5 d](/filings/0001852131-25-000064.md) | [4.7 d](/filings/0001852131-26-000006.md) | [17.8 d](/filings/0001852131-26-000017.md) | [15.9](/filings/0001852131-26-000048.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001852131-25-000006.md) | [(552) d](/filings/0001852131-26-000017.md) | not reported | not reported | [0.0 d](/filings/0001852131-25-000006.md) | [0.0 d](/filings/0001852131-26-000017.md) | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-29) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-28) | Q2 FY2025 (2024-09-27) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-27) | Q2 FY2026 (2025-09-26) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [147](/filings/0001852131-24-000015.md) | [147](/filings/0001852131-24-000025.md) | [147](/filings/0001852131-25-000006.md) | [149](/filings/0001852131-25-000050.md) | [149](/filings/0001852131-25-000064.md) | [149](/filings/0001852131-26-000006.md) | [151](/filings/0001852131-26-000048.md) | [152](/filings/0001852131-25-000064.md) | [154](/filings/0001852131-26-000006.md) | [155](/filings/0001852131-26-000048.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 136,542,423 at 2024-01-31, from the cover of the [10-Q filed 2024-02-07](/filings/0001628280-24-003593.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.